SV2A density

There is 1 paper on SV2A density in aging research: 1 observational study in people.

Biomarker

1 paper studies it2 more mention it5 findings

See all 3 papers on SV2A density

“observed disease- and region-specific reductions, with the most severe in FTLD-GRN (up to 59.5%) and EOAD.”
Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretationActa neuropathologica2024doi:10.1007/s00401-024-02816-9
  • Humans1

Associations

5

SYP density

upin humans1

1 study
  1. SV2A density is associated with SYP density in humans (strong positive correlation).

    Humansbrain

More on SYP density

Progressive supranuclear palsy

downin humans1

1 study
  1. Progressive supranuclear palsy is associated with SV2A density in humans (compared with healthy controls).

    Humanscompared with healthy controlshippocampal formation

More on Progressive supranuclear palsy

Late-onset Alzheimer's disease

downin humans1

1 study
  1. Late-onset Alzheimer's disease is associated with SV2A density in humans (compared with healthy controls) (over 30% declines).

    Humanscompared with healthy controlsinferior frontal gyrus and hippocampal CA1

More on Late-onset Alzheimer's disease

Early-onset Alzheimer's disease

downin humans1−49% reduction

1 study
  1. Early-onset Alzheimer's disease is associated with SV2A density in humans (compared with healthy controls) (49% reduction).

    Humanscompared with healthy controlsmiddle frontal gyrus

More on Early-onset Alzheimer's disease

Frontotemporal lobar degeneration

downin humans1−60% reduction

1 study
  1. Frontotemporal lobar degeneration is associated with SV2A density in humans (FTLD-GRN compared with healthy controls) (up to 59.5% reduction).

    HumansFTLD-GRN compared with healthy controlscerebral cortex

More on Frontotemporal lobar degeneration

Latest